Symbols

BCPC

Balchem·NASDAQ

--(--)

Signals Analysis

Bullish signal 3

Bearish signal 1

Consensus Rating "Strong Buy"

Ample Liquidity

Revenue Beats Expectation

EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About BCPC

Balchem Corporation

A global specialty ingredients company focused on Nutrition and Health

Industry

Chemicals

Established Date

Listing Date

12/22/2006

Exchange

NASDAQ Stock Exchange

Full-time Employees

1,352

Fiscal Year Ends

12-31

Website

www.balchem.com

Security Type

Common stock

Office address

5 Paragon Drive, Montvale, NJ 07645

Business

Introduction

Baiche was incorporated in Maryland in 1967. The company develops, manufactures, distributes and sells specialty performance ingredients and products for nutrition, food, pharmaceutical, animal health, plant nutrition, sterilization, fumigation and industrial markets. The company's three reportable segments are strategic businesses that provide products and services to different markets: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.

Company Financials

EPS

BCPC has released its 2025 Q4 earnings. EPS was reported at 1.31, versus the expected 1.18, beating expectations. The chart below visualizes how BCPC has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

BCPC has released its 2025 Q4 earnings report, with revenue of 263.62M, reflecting a YoY change of 9.84%, and net profit of 39.23M, showing a YoY change of 16.80%. The Sankey diagram below clearly presents BCPC's revenue sources and cost distribution.